Cargando…
Novel synaptobrevin‐1 mutation causes fatal congenital myasthenic syndrome
OBJECTIVE: To identify the molecular basis and elucidate the pathogenesis of a fatal congenital myasthenic syndrome. METHODS: We performed clinical electrophysiology studies, exome and Sanger sequencing, and analyzed functional consequences of the identified mutation. RESULTS: Clinical electrophysio...
Autores principales: | Shen, Xin‐Ming, Scola, Rosana H., Lorenzoni, Paulo J., Kay, Cláudia S. K., Werneck, Lineu C., Brengman, Joan, Selcen, Duygu, Engel, Andrew G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288468/ https://www.ncbi.nlm.nih.gov/pubmed/28168212 http://dx.doi.org/10.1002/acn3.387 |
Ejemplares similares
-
Congenital myasthenic syndrome in a cohort of patients with ‘double’ seronegative myasthenia gravis
por: Lorenzoni, Paulo José, et al.
Publicado: (2021) -
Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes—A Comprehensive Review
por: Ohno, Kinji, et al.
Publicado: (2023) -
Fundamental Gating Mechanism of Nicotinic Receptor Channel Revealed by Mutation Causing a Congenital Myasthenic Syndrome
por: Wang, Hai-Long, et al.
Publicado: (2000) -
Hereditary Neuropathy With Liability to Pressure Palsies: A Single-Center Experience in Southern Brazil
por: Lorenzoni, Paulo José, et al.
Publicado: (2016) -
Somatosensory evoked potentials in Hirayama disease: A Brazilian study
por: Fustes, Otto Hernandez, et al.
Publicado: (2020)